What is LSVT Global?
Originating in 2003 from the foundational Lee Silverman Voice Therapy, LSVT Global has evolved into a comprehensive therapeutic powerhouse. The organization is best known for its flagship protocols, LSVT LOUD and LSVT BIG, which are specifically engineered to address the debilitating effects of Parkinson's disease. Through a rigorous model of professional training, the company has successfully certified over 19,000 speech-language pathologists across 70 countries and more than 16,000 physical and occupational therapists in 42 nations. This extensive network of trained clinicians ensures that the company's research-backed methodologies are accessible to a global patient population, effectively bridging the gap between clinical research and practical, daily patient care.
How much funding has LSVT Global raised?
LSVT Global has raised a total of $356K across 2 funding rounds:
Debt
$150K
Debt
$206K
Debt (2020): $150K with participation from PPP
Debt (2021): $206K led by PPP
Key Investors in LSVT Global
PPP
Public-Private Partnership
What's next for LSVT Global?
With the recent influx of capital, LSVT Global is well-positioned to accelerate its strategic initiatives, focusing on the digitization of its training platforms and the expansion of its clinical footprint. The company's late-stage funding status suggests a transition toward market consolidation and the potential for further integration into global healthcare systems. Future growth will likely center on enhancing the efficacy of its digital health offerings and deepening its research pipeline to address a broader spectrum of neurological conditions. By maintaining its focus on high-quality, evidence-based outcomes, LSVT Global is poised to remain at the forefront of the neuro-rehabilitation industry, driving long-term value for both its clinical partners and the patients they serve.
See full LSVT Global company page
